P-959 A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC)

✍ Scribed by Liao, Z.; Komaki, R.; Milas, L.; Chen, Y.; Kies, M.; Chang, J.; Jeter, M.; Guerrero, T.; Blumenschein, G.; Cox, J.

• Book ID: 122905797
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 147 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(05)81452-7